This federal Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The $40 million IDC, titled "Pre-Clinical Models of Infectious Diseases", has an ultimate completion date of July 13, 2024 and is part of the larger NIAID Preclinical Models of...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to the American Foundation For Biological Research, doing business as the Biomedical Research Institute. The $146.3 million single-award IDC has a period of performance from July 15, 2024 to July 14, 2031. The purpose of this IDC is to provide NIAID with the capability and capacity to develop and employ...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to The Charles Stark Draper Laboratory, Inc. (Draper) for the development and employment of animal and animal replacement models of infectious diseases. The $146.3 million single-award IDC has a 7-year ordering period and supports the full range of preclinical evaluations, including screening, product evaluation, and eventual clinical evaluation of...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services, awarded a $146.3 million Indefinite Delivery Contract (IDC) to Institute For Clinical Pharmacodynamics, Inc., a for-profit organization, to provide pre-clinical models of infectious diseases under Task Area C. The period of performance is from July 15, 2024 to July 14, 2031. The contract is a follow-on to a previous Preclinical Models of Infectious Diseases...
This Indefinite Delivery Contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services, to Emory University, a private research university. The contract has a ceiling value of $146,300,000 and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with the capability to develop, refine, and employ small animal models, non-human primate models, animal...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $146.3 million single-award Indefinite Delivery Contract (IDC) to the UK Health Security Agency (formerly Public Health England) to provide preclinical services in support of the development of medical countermeasures against chemical, biological, radiological, and nuclear threats. The contract includes task areas for small animal models, non-human primate models, animal replacement and non-traditional animal models,...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a single-award, $146.3 million Indefinite Delivery Contract (IDC) to The Research Foundation For The State University Of New York to develop and employ animal and animal replacement models of infectious diseases for screening, product evaluation, and eventual clinical evaluation. This IDC contains four task areas: Task Area A - Small Animal Models of Infectious Diseases Task Area B - Non-Human Primate Models of...
This Indefinite Delivery Contract (IDC), awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, is focused on providing pre-clinical models of infectious diseases. The $146.3 million single-award contract was granted to The Regents of the University of California, San Francisco (UCSF), a U.S. state government and educational institution, for a period of performance from July 2024 through April 2030. The contract aims to develop and refine animal and...
The indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to the University of Georgia Research Foundation, Inc. (UGA Research Foundation), a non-profit organization. The single-award IDC has a ceiling value of $146.3 million over 7 years and focuses on developing and employing animal and animal replacement models of infectious diseases to support NIAID's pandemic preparedness...
This indefinite delivery contract (IDC) awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Midwest Research Institute (doing business as Mriglobal) aims to provide pre-clinical evaluation of infectious disease countermeasures. The $146.3 million single-award IDC has a period of performance through August 2024.
The contract covers the development and refinement of small animal, non-human primate, and animal replacement/non-traditional models to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of candidate vaccines, therapeutics, and diagnostics targeting priority infectious disease areas. These include RNA viruses with pandemic potential, antimicrobial resistant infections, emerging/re-emerging infectious diseases, neglected tropical diseases, and sexually transmitted infections. The contract also includes the generation and distribution of specialized infectious disease research reagents. This IDC is expected to support NIAID's mission of advancing critical medical countermeasures through the product development pipeline.